|
|
||||||||
1 Institute of Molecular Biology and Medicine, and 2 National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan, 3 Dept of Pathophysiology, Free University of Brussels, Brussels, Belgium, and 4 Section of Experimental Medicine and Toxicology, Imperial College London, Hammersmith Hospital, London, United Kingdom.
CORRESPONDENCE: M. R. Wilkins, Section of Experimental Medicine and Toxicology, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK. Fax: 44 2083832066. E-mail: m.wilkins{at}imperial.ac.uk
Keywords: ECG, echocardiography, high-altitude pulmonary hypertension, pulmonary circulation, right heart catheterisation
Received: November 22, 2005
Accepted October 12, 2006
The purpose of the present study was to evaluate Doppler echocardiography for the detection of pulmonary hypertension in high-altitude inhabitants.
In total, 60 (55 male) patients aged 1871 yrs were recruited from an ECG screening programme applied to 1,430 inhabitants living at an altitude of 2,5003,600 m in Kyrgyzstan. Of these, 44 met ECG criteria for right ventricular hypertrophy. All underwent Doppler echocardiography followed by a cardiac catheterisation within 7 days of arrival in Bishkek (Kyrgyzstan; altitude 760 m). Pulmonary flow acceleration time and the maximum velocity of tricuspid regurgitation were measured.
Sufficient quality tricuspid regurgitant jets were recovered in only 28% of the patients. Therefore, pulmonary artery pressure was estimated from the pulmonary flow acceleration time, which was recovered in 100% of the patients. It was found that 37 (62%) of the patients had pulmonary hypertension on echocardiography. Pulmonary hypertension was confirmed in 29 patients on catheterisation. Pulmonary hypertension was detected with 70% sensitivity and 88% specificity by echocardiography, as compared to 59% sensitivity and 81 % specificity by ECG. The correlation coefficient between echocardiography and catheterisation studies was r2 = 0.78.
It is concluded that a combination of ECG and echocardiography may be useful for screening high-altitude pulmonary hypertension.
This article has been cited by other articles:
![]() |
J.-P. Richalet, M. Rivera-Ch, M. Maignan, C. Privat, I. Pham, J.-L. Macarlupu, O. Petitjean, and F. Leon-Velarde Acetazolamide for Monge's Disease: Efficiency and Tolerance of 6-Month Treatment Am. J. Respir. Crit. Care Med., June 15, 2008; 177(12): 1370 - 1376. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |